Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin K S Wong

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Translational Research : the Journal of Laboratory and Clinical Medicine|December 4, 2014
Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndromeEdwin K S Wong, David Kavanagh
Seminars in Immunopathology|January 13, 2018
Diseases of complement dysregulation-an overviewEdwin K S Wong, David Kavanagh
Oxford Medical Case Reports|May 20, 2015
Sarcoidosis presenting with hypercalcaemia following withdrawal of long-term immunosuppression in renal transplantationEdwin K S Wong, Akhtar Husain, John A Sayer
Molecular Immunology|July 2, 2013
Complement therapy in atypical haemolytic uraemic syndrome (aHUS)Edwin K S Wong, Tim H J Goodship, David Kavanagh
Pediatric Nephrology (Berlin, Germany)|July 16, 2013
Making sense of the spectrum of glomerular disease associated with complement dysregulationSally Ann Johnson, Edwin K S Wong, C Mark Taylor
Clinical Kidney Journal|June 20, 2014
Atypical haemolytic uraemic syndrome associated with a <i>CD46</i> mutation triggered by <i>Shigella flexneri.</i>Vicky Brocklebank, Edwin K S Wong, Rick Fielding, et al.
Kidney International|June 29, 2025
Quantifying association of early proteinuria and estimated glomerular filtration rate changes with long-term kidney failure in C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis using the United Kingdom RaDaR RegistrySherry Masoud, Katie Wong, David Pitcher, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 10, 2025
Late Onset Thrombotic Microangiopathy in Kidney Transplants; Poor Outcome Despite Eculizumab TreatmentEmily K Glover, Emma K Montgomery, Edwin K S Wong, et al.
Kidney International|July 30, 2015
An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathyEva-Maria Nichols, Thomas D Barbour, Isabel Y Pappworth, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 10, 2017
Hemolytic Uremic Syndrome in Pregnancy and PostpartumAlexandra Bruel, David Kavanagh, Marina Noris, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Translational Research : the Journal of Laboratory and Clinical Medicine|December 4, 2014
Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndromeEdwin K S Wong, David Kavanagh
Seminars in Immunopathology|January 13, 2018
Diseases of complement dysregulation-an overviewEdwin K S Wong, David Kavanagh
Oxford Medical Case Reports|May 20, 2015
Sarcoidosis presenting with hypercalcaemia following withdrawal of long-term immunosuppression in renal transplantationEdwin K S Wong, Akhtar Husain, John A Sayer
Molecular Immunology|July 2, 2013
Complement therapy in atypical haemolytic uraemic syndrome (aHUS)Edwin K S Wong, Tim H J Goodship, David Kavanagh
Pediatric Nephrology (Berlin, Germany)|July 16, 2013
Making sense of the spectrum of glomerular disease associated with complement dysregulationSally Ann Johnson, Edwin K S Wong, C Mark Taylor
Clinical Kidney Journal|June 20, 2014
Atypical haemolytic uraemic syndrome associated with a <i>CD46</i> mutation triggered by <i>Shigella flexneri.</i>Vicky Brocklebank, Edwin K S Wong, Rick Fielding, et al.
Kidney International|June 29, 2025
Quantifying association of early proteinuria and estimated glomerular filtration rate changes with long-term kidney failure in C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis using the United Kingdom RaDaR RegistrySherry Masoud, Katie Wong, David Pitcher, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 10, 2025
Late Onset Thrombotic Microangiopathy in Kidney Transplants; Poor Outcome Despite Eculizumab TreatmentEmily K Glover, Emma K Montgomery, Edwin K S Wong, et al.
Kidney International|July 30, 2015
An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathyEva-Maria Nichols, Thomas D Barbour, Isabel Y Pappworth, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 10, 2017
Hemolytic Uremic Syndrome in Pregnancy and PostpartumAlexandra Bruel, David Kavanagh, Marina Noris, et al.
Pageof 3